Sustainable API Process R&D Enabled by Continuous Manufacturing (Flow Chemistry)
Published on 03-23-202203:59 PM by
qpham289| Updated on 03-23-202203:59 PM
Continuous manufacturing (flow chemistry) is a key element in the green-chemistry landscape of a pharmaceutical company. In this webinar, Benjamin Martin, PhD from Novartis will use case studies to illustrate the drivers for continuous processing for clinical supplies, the challenges navigated during process R & D, and a summary of how the sustainability metrics, Process-Mass-Intensity (PMI) and Total CO2-Release (TCR), are positively affected.
Hongwei Yang, PhD from WuXi STA will show how industry collaboration between Pharma companies and CDMOs with strong capability to quickly develop or transfer in a flow process and assemble customized lines at plant-scale can accelerate the implementation of continuous manufacturing for drug substance supply with a cost-effective and greener process.
Key Learning Objectives:
Sustainability metrics for continuous manufacturing (CM) in pharmaceutical industry
Key drivers for using CM at the clinical stages
How Innovators and CDMOs can work together to speed implementation of CM and bring therapies to patients faster.
Who Should Attend:
Pharmaceutical & Fine Chemists
Academic Chemistry Researchers
Process & Development Chemists
Drug Discovery Chemists
Brought to you by:
Benjamin Martin, Ph.D. Associate Director Science & Technology Continuous Manufacturing-Upstream Network Leader, Novartis
Hongwei Yang, Ph.D. Executive Director and Head of Flow Chemistry, WuXi STA, a subsidiary of WuXi AppTec
Melissa O'Meara Forensic Science Consultant, C&EN Media Group